Combination therapy with human amniotic epithelial cells and hyaluronic acid promotes immune balance recovery in type 1 diabetic rats through local engraftment
Scandinavian Journal of Immunology · 2023
DOI: 10.1111/sji.13246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, 2023. Verfasst von Ya-Wei Cheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicinal Biotechnology, Affiliated Hospital of Zunyi Medical University, Zunyi, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Foundation of Zunyi Science and Technology Bureau, Guizhou High-Level Innovative Talent Support Program and S&T Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Stem cell engraftment is currently a promising approach for type 1 diabetes mellitus (T1DM) treatment. In our previous study, engraftment of a combination of human amniotic epithelial cells (hAECs) and hyaluronic acid (HA) showed potent anti‐diabetic effect in streptozotocin (STZ)‐induced T1DM mice via tail vein injection. Here, we adopted a different route of stem cell delivery, that is via pancreatic subcapsular transplantation. This combined local engraftment of hAECs and HA in STZ‐induced T1DM rats showed potent anti‐diabetic activity, leading to stronger hypoglycaemia, more intact islet structure and increased number of insulin‐positive cells compared with those with hAECs or insulin treatments. Engraftment of hAECs alone increased the proportion of Th1 and T‐reg cells and decreased the proportion of Th2 and Th17 cells to protect islet β cells in STZ‐induced T1DM rats, whereas the combined engraftment of hAECs and HA showed more potent regulatory capacity, considerably decreased the level of TNF‐α and IL‐17 and increased the level of TGF‐β1 compared with those by other treatments. The potent synergistic effect of HA contributed to the recovery of immune balance in the diabetic rat model, thereby suggesting a new strategy for effective treatment of T1DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medicinal Biotechnology, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
- Zunyi Municipal Key Laboratory of Medicinal Biotechnology & Guizhou Provincial Research Center for Translational Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
ORCID-Profile: Yi Luo, Jian-Hui Xiao
Förderung
- Foundation of Zunyi Science and Technology Bureau
- Guizhou High-Level Innovative Talent Support Program and S&T Foundation
- National Natural Science Foundation of China
- Science and Technology Innovation Leading Academics of National High-level Personnel of Special Support Program
Zitieren
APA
Cheng, Y. W., Luo, Y., Zheng, S. J., & Xiao, J. H. (2023). Combination therapy with human amniotic epithelial cells and hyaluronic acid promotes immune balance recovery in type 1 diabetic rats through local engraftment. Scandinavian Journal of Immunology. https://doi.org/10.1111/sji.13246
Vancouver
Cheng YW, Luo Y, Zheng SJ, Xiao JH. Combination therapy with human amniotic epithelial cells and hyaluronic acid promotes immune balance recovery in type 1 diabetic rats through local engraftment. Scandinavian Journal of Immunology. 2023. doi:10.1111/sji.13246
BibTeX
@article{Cheng2023,
author = {Cheng, Ya-Wei and Luo, Yi and Zheng, Shu-Juan and Xiao, Jian-Hui},
title = {Combination therapy with human amniotic epithelial cells and hyaluronic acid promotes immune balance recovery in type 1 diabetic rats through local engraftment},
journal = {Scandinavian Journal of Immunology},
year = {2023},
doi = {10.1111/sji.13246}
}
EUVIMED